In This Section

San Antonio Breast Cancer Symposium 2025 Press Program

UT Health San Antonio and the American Association for Cancer Research (AACR) are co-sponsors of the San Antonio Breast Cancer Symposium 2025 (SABCS) at the Henry B. Gonzalez Convention Center in San Antonio, Texas.

Each year, SABCS features the latest research on the biology, etiology, prevention, diagnosis, and treatment of breast cancer and premalignant breast disease, including data from late-breaking clinical trials. Each year, the symposium attracts thousands of basic researchers, physician-scientists, clinical investigators, breast care providers, and advocates from around the world.

Press conference 1

SABCS Program Director Kate Lathrop, MD, UT Health San Antonio, moderated the first press conference on Wednesday, December 10.

The following studies were presented:

Adding Tucatinib to First-line Maintenance Therapy Delayed Disease Progression in HER2-positive Metastatic Breast Cancer in HER2CLIMB-05 Trial

  • Presented by Erika Hamilton, MD, Sarah Cannon Research Institute

Sacituzumab Govitecan-hziy Led to Similar Progression-free Survival as Standard of Care for Certain Endocrine Therapy-refractory Advanced Breast Cancers

  • Presented by Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center

Novel Endocrine Therapy Giredestrant Improves Disease-free Survival Over Standard of Care for Patients With Early-stage Breast Cancer in Phase III lidERA Trial

  • Presented by Aditya Bardia, MD, MPH, University of California, Los Angeles Jonsson Comprehensive Cancer Center
VIEW PRESS CONFERENCE 1

Press conference 2

SABCS Codirector Carlos Arteaga, MD, FAACR, Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center, moderated the second press conference on Thursday, December 11.

The following studies were presented:

Preoperative Radiation May Improve Antitumor Immune Response in Most Common Form of Breast Cancer

  • Presented by Gaorav Gupta, MD, PhD, University of North Carolina Lineberger Comprehensive Cancer Center

Breast MRI May Be Safely Omitted From Diagnostic Workup in Certain Patients With Early-stage, HR-negative Breast Cancer

  • Presented by Isabelle Bedrosian, MD, The University of Texas MD Anderson Cancer Center

Sentinel Lymph Node Biopsy May Be Safely Omitted in Some Patients With Early-stage Breast Cancer

  • Presented by Marjolein Smidt, MD, PhD, Maastricht University Medical Center in the Netherlands
VIEW PRESS CONFERENCE 2

Press conference 3

SABCS Codirector Virginia Kaklamani, MD, UT Health San Antonio, moderated the third and final press conference on Friday, December 12.

The following studies were presented:

Menopausal Hormone Therapy May Not Pose Breast Cancer Risk for Women With BRCA Mutations

  • Presented by Joanne Kotsopoulos, PhD, Women’s College Hospital Research and Innovation Institute, Dalla Lana School of Public Health at the University of Toronto in Canada

Mobile Health Tool May Improve Quality of Life for Adolescent and Young Adult Breast Cancer Survivors

  • Presented by Ann H. Partridge, MD, MPH, Dana-Farber Cancer Institute

Acupuncture May Help Improve Perceived Breast Cancer-related Cognitive Difficulties Over Usual Care

  • Presented by Jun J. Mao, MD, MSCE, Memorial Sloan Kettering Cancer Center
View press conference 3

Additional press release

A Multimodal AI Model May Improve Recurrence Risk Stratification in Early Breast Cancer

  • Presented by Joseph A. Sparano, MD, Mount Sinai Tisch Cancer Center

Past Press Program

Press Program 2024 Press Program 2023